Evidence map›Paper›PMID 38339035›Full record

ReviewInternational journal of molecular sciences2024

Presenilin: A Multi-Functional Molecule in the Pathogenesis of Alzheimer's Disease and Other Neurodegenerative Diseases.

Yang Sun, Sadequl Islam, Makoto Michikawa, Kun Zou

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Beyond Wolfram Syndrome 1: TheBiomolecules · 2024
    Review
  9. Article
  10. Protein Oxidation in Aging and Alzheimer's Disease Brain.Antioxidants (Basel, Switzerland) · 2024
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yang SunDepartment of Biochemistry, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.
Sadequl IslamDepartment of Biochemistry, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.
Makoto MichikawaDepartment of Geriatric Medicine, School of Life Dentistry at Niigata, The Nippon Dental University, Niigata 951-8580, Japan.
Kun ZouDepartment of Biochemistry, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.
Nagoya City University · JPNippon Dental University · JP

Funding

AMED JP20dk0207050h0001 and JP20de010702Daiko Foundation noDaiwa Securities Foundation noHirose Foundation noHirose International Scholarship Foundation noHori Sciences and Arts Foundation noThe 24th General Assembly of the Japanese Association of Medical Sciences noThe Grant-in-Aid for Scientific Research C19K07846The Ministry of Education, Culture, Sports, Science, and Technology, Japan. 22K07352
6 · The paper itself

Abstract

Presenilin, a transmembrane protein primarily known for its role in Alzheimer's disease (AD) as part of the γ-secretase complex, has garnered increased attention due to its multifaceted functions in various cellular processes. Recent investigations have unveiled a plethora of functions beyond its amyloidogenic role. This review aims to provide a comprehensive overview of presenilin's diverse roles in AD and other neurodegenerative disorders. It includes a summary of well-known substrates of presenilin, such as its involvement in amyloid precursor protein (APP) processing and Notch signaling, along with other functions. Additionally, it highlights newly discovered functions, such as trafficking function, regulation of ferritin expression, apolipoprotein E (ApoE) secretion, the interaction of ApoE and presenilin, and the Aβ42-to-Aβ40-converting activity of ACE. This updated perspective underscores the evolving landscape of presenilin research, emphasizing its broader impact beyond established pathways. The incorporation of these novel findings accentuates the dynamic nature of presenilin's involvement in cellular processes, further advancing our comprehension of its multifaceted roles in neurodegenerative disorders. By synthesizing evidence from a range of studies, this review sheds light on the intricate web of presenilin functions and their implications in health and disease.

Indexed as

Alzheimer DiseaseNeurodegenerative DiseasesAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesApolipoproteins EHumansPresenilin-1Presenilin-2Amyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesApolipoproteins EPresenilin-1Presenilin-2ALSAlzheimer’s diseaseApoEAβ42-to-Aβ40-converting activity of ACEFTDHDneurodegenerative diseasesPDpresenilintrafficking

Identifiers

PMID38339035
PMCPMC10855926
OpenAlexW4391449730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.